Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Red stop sign on road
Biotech

Verdiva axes GLP-1 switching trial over ‘market evolution’

Verdiva Bio has scrapped a phase 2 trial of its once-weekly oral GLP-1 drug candidate, pulling the plug the year after launching with $410 million.
Nick Paul Taylor Oct 14, 2026 10:13am
Yellow tape measure with a variety of weight loss medication on blue background

Biomea posts data to pitch oral GLP-1 to potential partners

Oct 14, 2026 9:23am
iRegene Therapeuticss NouvSight001 Cleared for Clinical Trials in the US and China for Retinitis Pigmentosa

iRegene Therapeutics’s NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa

Brought to you by iRegene Therapeutics
Gilead Kite booth at AACR 2026

Vir CEO sees chance ‘to do more deals’ after $1.9B Gilead pact

Oct 14, 2026 8:30am
video
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
GSK RD headquarters in Wavre Belgium

GSK to lay off 1,200 roles in Belgium under cost-saving program

Oct 14, 2026 6:37am